Literature DB >> 24867861

Intracranial idiopathic hypertension: 1-year follow-up study.

D D'Amico1, M Curone, A Erbetta, G Farago', S Bianchi-Marzoli, P Ciasca, G Bussone, L Chiapparini.   

Abstract

Standard guidelines for ongoing management, as well as definitive data about the long-term course of idiopathic intracranial hypertension (IIH) are not available. The aim of this study was to compare several clinical and instrumental variables as assessed at the time of diagnosis and then after 1 year in a sample of IIH patients. A total of 21 patients were studied. Our results confirmed that headache and TVO are the most frequent symptoms in IIH patients, and that overweight is a very common feature. A trend towards a favorable outcome in patients followed for 1 year and treated by usual medical therapy was found: intracranial pressure was lower at follow-up; improvement of headache and transient visual obscurations, as well as of papilledema, was reported in most patients. On the other hand, neuroradiological findings (such as empty sella, perioptic subarachnoid space distension, narrowing of the transverse sinuses) were substantially stable at follow. These findings may be relevant for future research as far as understanding the role of different clinical and instrumental findings as diagnostic items as well as predictors of outcome in IIH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867861     DOI: 10.1007/s10072-014-1765-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  12 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  Imaging characteristics of IIH: are they reliable?

Authors:  Kathleen B Digre
Journal:  Cephalalgia       Date:  2013-04-19       Impact factor: 6.292

3.  Morphometric and volumetric MRI changes in idiopathic intracranial hypertension.

Authors:  Jan Hoffmann; Hans-Jürgen Huppertz; Christoph Schmidt; Hagen Kunte; Lutz Harms; Randolf Klingebiel; Edzard Wiener
Journal:  Cephalalgia       Date:  2013-04-24       Impact factor: 6.292

Review 4.  Advancement in idiopathic intracranial hypertension pathogenesis: focus on sinus venous stenosis.

Authors:  Roberto De Simone; Angelo Ranieri; Vincenzo Bonavita
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

Review 5.  The syndrome of pseudotumour cerebri and idiopathic intracranial hypertension.

Authors:  Clare Fraser; Gordon T Plant
Journal:  Curr Opin Neurol       Date:  2011-02       Impact factor: 5.710

6.  Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study.

Authors:  Maren Skau; Birgit Sander; Dan Milea; Rigmor Jensen
Journal:  J Neurol       Date:  2010-09-19       Impact factor: 4.849

7.  Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children.

Authors:  Deborah I Friedman; Grant T Liu; Kathleen B Digre
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

8.  Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis.

Authors:  R I Farb; I Vanek; J N Scott; D J Mikulis; R A Willinsky; G Tomlinson; K G terBrugge
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

9.  Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH).

Authors:  D D Amico; M Curone; P Ciasca; G Cammarata; L Melzi; G Bussone; S Bianchi Marzoli
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

10.  Clinical course of idiopathic intracranial hypertension with transverse sinus stenosis.

Authors:  Bryan D Riggeal; Beau B Bruce; Amit M Saindane; Maysa A Ridha; Linda P Kelly; Nancy J Newman; Valérie Biousse
Journal:  Neurology       Date:  2012-12-26       Impact factor: 9.910

View more
  1 in total

1.  Course and Predictors of Visual Outcome of Idiopathic Intracranial Hypertension.

Authors:  Raed Behbehani; Abdullah Ali; Ashraf Al-Moosa
Journal:  Neuroophthalmology       Date:  2021-10-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.